Treatment of Compound Tibia Fracture With a Microvascular Latissimus Dorsi Flap and the Ilizarov Technique
1 other identifier
observational
9
1 country
1
Brief Summary
This study assesses the long-term results of compound tibial reconstruction treated with a microvascular latissimus dorsi flap and bone transport technique during the last 25 year in Helsinki University central Hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
February 18, 2015
CompletedFirst Posted
Study publicly available on registry
February 24, 2015
CompletedMay 14, 2015
May 1, 2015
8 months
February 18, 2015
May 12, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Disabilities of the Arm, Shoulder and Hand (DASH)
Assesses the function of the donor site
10-25 years
The 15-Dimensions Health-Related Quality of Life (HRQoL) instrument.
Assesses the HRQoL
10-25 years
Lower Extremity Functional Scale (LEFS)
Assesses the function of the reconstructed limb
10-25 years
Interventions
Patients were treated with free latissimus dorsi flap and bone transport technique
Eligibility Criteria
Patients with acute compound tibial fracture or sequela treated with free latissimus dorsi flap and bone transport
You may qualify if:
- Age over 15 years.
- Patients with acute compound tibial fracture or sequela treated with free latissimus dorsi flap and bone transport.
You may not qualify if:
- Deceased.
- Patients under 15 years of age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Helsinki University Central Hospital
Helsinki, Uusimaa, 00029, Finland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Erkki J. Tukiainen, PhD, MD
Helsinki University Hospital, Department of Plastic and Reconstructive Surgery.
Study Design
- Study Type
- observational
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
February 18, 2015
First Posted
February 24, 2015
Study Start
June 1, 2014
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
May 14, 2015
Record last verified: 2015-05